Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method

References

• Javan F, Vatanara A, Azadmanesh K, et al. Encapsulation of ritonavir in solid lipid nanoparticles: in-vitro anti-HIV-1 activity using lentiviral particles. J Pharm Pharmacol. 2017;69(8):1002–1009.
   PubMed Web of Science ®Google Scholar
• Sosnik A, Amiji M. Nanotechnology solutions for infectious diseases in developing nations. Preface Adv Drug Deliv Rev. 2010;62(4-5):375–377.
   PubMed Web of Science ®Google Scholar
• Sosnik A, Chiappetta DA, Carcaboso ÁM. Drug delivery systems in HIV pharmacotherapy: What has been done and the challenges standing ahead. J Control Release. 2009;138(1):2–15.
   PubMed Web of Science ®Google Scholar
• Ojewole E, Mackraj I, Naidoo P, et al. Exploring the use of novel drug delivery systems for antiretroviral drugs. Eur J Pharm Biopharm. 2008;70(3):697–710.
   PubMed Web of Science ®Google Scholar
• Ahammed V, Narayan R, Paul J, et al. Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting. Life Sci. 2017;183:11–20.
   PubMed Web of Science ®Google Scholar
• Sudhakar B, Krishna MC, Murthy KVR. Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies. Appl Nanosci. 2016;6(1):43–60.
   Web of Science ®Google Scholar
• Law D, Krill SL, Schmitt EA, et al. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J Pharm Sci. 2001;90(8):1015–1025.
   PubMed Web of Science ®Google Scholar
• Law D, Schmitt EA, Marsh KC, et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci. 2004;93(3):563–570.
   PubMed Web of Science ®Google Scholar
• Siriwannakij N, Heimbach T, Serajuddin ATM. Aqueous dissolution and dispersion behavior of polyvinylpyrrolidone vinyl acetate-based amorphous solid dispersion of ritonavir prepared by Hot-Melt extrusion with and without added surfactants. J Pharm Sci. 2021;110(4):1480–1494.
   PubMed Web of Science ®Google Scholar
• LaFountaine JS, Jermain SV, Prasad LK, et al. Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing. Eur J Pharm Biopharm. 2016;101:72–81.
   PubMed Web of Science ®Google Scholar
• Sinha S, Ali M, Baboota S, et al. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech. 2010;11(2):518–527.
   PubMed Web of Science ®Google Scholar
• LaFountaine JS, McGinity JW, Williams RO. Challenges and strategies in thermal processing of amorphous solid dispersions: a review. AAPS PharmSciTech. 2016;17(1):43–55.
   PubMed Web of Science ®Google Scholar
• Shah SP, Breitenbach J. Melt extrusion: a commercial perception to practicality. Melt extrusion. New York: Springer; 2013. p. 447–458.
   Google Scholar
• Thakuria R, Delori A, Jones W, et al. Pharmaceutical cocrystals and poorly soluble drugs. Int J Pharm. 2013;453(1):101–125.
   PubMed Web of Science ®Google Scholar
• Aitipamula S, Banerjee R, Bansal AK, et al. Polymorphs, salts, and cocrystals: What’s in a name? Crystal Growth Design. 2012;12(5):2147–2152.
   Web of Science ®Google Scholar
• Kuminek G, Cao F, Bahia de Oliveira da Rocha A, et al. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5. Adv Drug Deliv Rev. 2016;101:143–166.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zu H, Zhang J. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation: Adefovir dipivoxil cocrystal. J Pharm Pharmacol. 2011;63(4):483–490.
   PubMed Web of Science ®Google Scholar
• Basavoju S, Boström D, Velaga SP. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res. 2008;25(3):530–541.
   PubMed Web of Science ®Google Scholar
• Good DJ, Rodríguez-Hornedo N. Solubility advantage of pharmaceutical cocrystals. Crystal Growth Design. 2009;9(5):2252–2264.
   Web of Science ®Google Scholar
• Trask AV. An overview of pharmaceutical cocrystals as intellectual property. Mol Pharm. 2007;4(3):301–309.
   PubMedGoogle Scholar
• Cerreia Vioglio P, Chierotti MR, Gobetto R. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges. Adv Drug Deliv Rev. 2017;117:86–110.
   PubMed Web of Science ®Google Scholar
• Izutsu K, Koide T, Takata N, et al. Characterization and quality control of pharmaceutical cocrystals. Chem Pharm Bull (Tokyo)). 2016;64(10):1421–1430.
   PubMed Web of Science ®Google Scholar
• Simms RW, Zerbini CAF, Ferrante N, et al. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med. 1992;92(4):368–374.
   PubMed Web of Science ®Google Scholar
• Dotan I, Riesenberg K, Toledano R, et al. Prevalence and characteristics of fibromyalgia among HIV-positive patients in Southern Israel. Clin Exp Rheumatol. 2016; 34(2 Suppl 96):S34–S39.
   PubMed Web of Science ®Google Scholar
• Banderet LE, Lieberman HR. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain Res Bull. 1989;22(4):759–762.
   PubMed Web of Science ®Google Scholar
• O'Brien C, Mahoney C, Tharion WJ, et al. Dietary tyrosine benefits cognitive and psychomotor performance during body cooling. Physiol Behav. 2007;90(2-3):301–307.
   PubMed Web of Science ®Google Scholar
• Jongkees BJ, Hommel B, Kühn S, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands-A review. J Psychiatr Res. 2015;70:50–57.
   PubMed Web of Science ®Google Scholar
• Hase A, Jung SE, Aan Het Rot M. Behavioral and cognitive effects of tyrosine intake in healthy human adults. Pharmacol Biochem Behav. 2015;133:1–6.
   PubMed Web of Science ®Google Scholar
• Mahoney CR, Castellani J, Kramer FM, et al. Tyrosine supplementation mitigates working memory decrements during cold exposure. Physiology & Behavior. 2007;92(4):575–582.
   PubMed Web of Science ®Google Scholar
• Annamala MK, Inampudi KK, Guruprasad L. Docking of phosphonate and trehalose analog inhibitors into M. tuberculosis mycolyltransferase Ag85C: Comparison of the two scoring fitness functions GoldScore and ChemScore, in the GOLD software. Bioinformation, an Open Access Forum. 2007;1(9):339–350.
   Google Scholar
• Ramesh M, Bharatam PV. Importance of hydrophobic parameters in identifying appropriate pose of CYP substrates in cytochromes. Eur J Med Chem. 2014;71:15–23.
   PubMed Web of Science ®Google Scholar
• Hiendrawan S, Veriansyah B, Widjojokusumo E, et al. Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid. Int J Pharm. 2016;497(1-2):106–113.
   PubMedGoogle Scholar
• Deng J-H, Lu T-B, Sun CC, Chen J-M. Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin. Eur J Pharm Sci. 2017;104:255–261.
   PubMed Web of Science ®Google Scholar
• Abramowitz R, Yalkowsky SH. Melting point, boiling point, and symmetry. Pharm Res. 1990;7(9):942–947.
   PubMed Web of Science ®Google Scholar
• Dengale SJ, Ranjan OP, Hussen SS, et al. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions. Eur J Pharm Sci. 2014;62:57–64.
   PubMed Web of Science ®Google Scholar
• Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009;9(6):2950–2967.
   PubMed Web of Science ®Google Scholar
• Duarte Í, Andrade R, Pinto JF, et al. Green production of cocrystals using a new solvent-free approach by spray congealing. Int J Pharm. 2016;506(1-2):68–78.
   PubMedGoogle Scholar
• Brittain HG. Pharmaceutical cocrystals: the coming wave of new drug substances. J Pharm Sci. 2013;102(2):311–317.
   PubMed Web of Science ®Google Scholar
• do Amaral LH, do Carmo FA, Amaro MI, et al. Development and characterization of dapsone cocrystal prepared by scalable production methods. AAPS PharmSciTech. 2018;19(6):2687–2699.
   PubMed Web of Science ®Google Scholar
• Chadha R, Rani D, Goyal P. Novel cocrystals of gliclazide: characterization and evaluation. CrystEngComm. 2016;18(13):2275–2283.
   Web of Science ®Google Scholar
• Zhou Z, Li W, Sun W-J, et al. Resveratrol cocrystals with enhanced solubility and tabletability. Int J Pharm. 2016;509(1-2):391–399.
   PubMedGoogle Scholar
• Shayanfar A, Jouyban A. Physicochemical characterization of a new cocrystal of ketoconazole. Powder Technol. 2014;262:242–248.
   Web of Science ®Google Scholar
• Chakraborty S, Ganguly S, Desiraju GR. Synthon transferability probed with IR spectroscopy: cytosine salts as models for salts of lamivudine. CrystEngComm. 2014;16(22):4732–4741.
   Web of Science ®Google Scholar
• Silverstein RM, Webster FX, Kiemle DJ, et al. Spectrometric identification of organic compounds. Wiley; 2014.
   Google Scholar
• Yadav R, Dixit V, Yogesh M, et al. Raman and IR spectral and DFT based vibrational and electronic characterization of isolated and zwitterionic forms of L-tyrosin. Pharm. Anal. Acta. 2015; 6:1–18.
   Google Scholar
• Zhang X, Sun F, Zhang T, et al. Three pharmaceuticals cocrystals of adefovir: Syntheses, structures and dissolution study. J Mol Struct. 2015;1100:395–400.
   Web of Science ®Google Scholar
• Seo J-W, Hwang K-M, Lee S-H, et al. Preparation and characterization of adefovir dipivoxil-stearic acid cocrystal with enhanced physicochemical properties. Pharm Dev Technol. 2018;23(9):890–899.
   PubMed Web of Science ®Google Scholar
• Sokal A, Pindelska E, Szeleszczuk L, et al. Pharmaceutical properties of two ethenzamide-gentisic acid cocrystal polymorphs: Drug release profiles, spectroscopic studies and theoretical calculations. Int J Pharm. 2017;522(1-2):80–89.
   PubMed Web of Science ®Google Scholar
• Du S, Wang Y, Wu S, et al. Two novel cocrystals of lamotrigine with isomeric bipyridines and in situ monitoring of the cocrystallization. Eur J Pharm Sci. 2017;110:19–25.
   PubMed Web of Science ®Google Scholar
• Setyawan D, Sari R, Yusuf H, et al. Preparation and characterization of artesunate-nicotinamide cocrystal by solvent evaporation and slurry method. Asian J. Pharm. Clin. Res. 2014;7(1):62–65.
   Google Scholar
• Sangeetha M, Mathammal R. Establishment of the structural and enhanced physicochemical properties of the cocrystal-2-benzyl amino pyridine with oxalic acid. J Mol Struct. 2017;1143:192–203.
   Web of Science ®Google Scholar
• Goud NR, Gangavaram S, Suresh K, et al. Novel furosemide cocrystals and selection of high solubility drug forms. J Pharm Sci. 2012;101(2):664–680.
   PubMed Web of Science ®Google Scholar
• Karimi-Jafari M, Padrela L, Walker GM, et al. Creating cocrystals: a review of pharmaceutical cocrystal preparation routes and applications. Crystal Growth & Design. 2018;18(10):6370–6387.
   Web of Science ®Google Scholar
• Sathisaran I, Dalvi S. Engineering cocrystals of poorly Water-Soluble drugs to enhance dissolution in aqueous medium. Pharmaceutics. 2018;10(3):108.
   PubMed Web of Science ®Google Scholar
• Chattoraj S, Shi L, Chen M, et al. Origin of deteriorated crystal plasticity and compaction properties of a 1:1 cocrystal between piroxicam and saccharin. Crystal Growth Design. 2014;14(8):3864–3874.
   Web of Science ®Google Scholar
• Persson A-S, Ahmed H, Velaga S, et al. Powder compression properties of paracetamol, paracetamol hydrochloride, and paracetamol cocrystals and coformers. J Pharm Sci. 2018;107(7):1920–1927.
   PubMed Web of Science ®Google Scholar
• Perumalla SR, Sun CC. Enabling tablet product development of 5-Fluorocytosine through integrated crystal and particle engineering. J Pharm Sci. 2014;103(4):1126–1132.
   PubMed Web of Science ®Google Scholar
• Joiris E, Martino PD, Berneron C, et al. Compression behavior of orthorhombic paracetamol. Pharm Res. 1998;15(7):1122–1130.
   PubMed Web of Science ®Google Scholar
• Jain H, Khomane KS, Bansal AK. Implication of microstructure on the mechanical behaviour of an aspirin–paracetamol eutectic mixture. CrystEngComm. 2014;16(36):8471–8478.
   Web of Science ®Google Scholar
• Perumalla SR, Shi L, Sun CC. Ionized form of acetaminophen with improved compaction properties. CrystEngComm. 2012;14(7):2389–2390.
   Web of Science ®Google Scholar
• Sun C, Grant DJW. Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharmaceutical Research. 2001;18(3):274–280.
   PubMed Web of Science ®Google Scholar
• Sun CC, Hou H. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Crystal Growth & Design. 2008 May;8(5):1575–1579.
   Web of Science ®Google Scholar